Serum proteomics and biomarker discovery
โ
Lauren N. Bell; Janice L. Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G. B
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 361 KB
๐ 2 views
Nonalcoholic fatty liver disease (NAFLD), ranging from relatively benign simple steatosis to progressive nonalcoholic steatohepatitis (NASH) and fibrosis, is an increasingly common chronic liver disease. Liver biopsy is currently the only reliable tool for staging the subtypes of NAFLD; therefore, n